
- Telehealth visits

Garani S. Nadaraja, MD
She | Her | HersPediatric Otolaryngology- Telehealth visits



Garani S. Nadaraja, MD
She | Her | HersPediatric Otolaryngology- Telehealth visits
On this page
About me
Dr. Garani S. Nadaraja is a surgeon who cares for children with ear, nose and throat problems. She has particular interests in pediatric hearing loss, chronic ear infections, cholesteatomas (abnormal skin growths in the middle ear), sinus disease, airway abnormalities, and snoring or sleep apnea. She is medical director and section chief of the pediatric otolaryngology service at UCSF Benioff Children's Hospital Oakland.
Nadaraja's research interests include understanding how socioeconomic disparities impact access to pediatric subspecialty care.
Nadaraja earned her medical degree from Northwestern University Feinberg School of Medicine. She completed a residency in otolaryngology – head and neck surgery at Stanford University School of Medicine and a fellowship in pediatric otolaryngology at Rady Children's Hospital – San Diego, an affiliate of the University of California, San Diego.
Education & training
Board certification
- Complex Pediatric Otolaryngology, American Board of Otolaryngology
- Otolaryngology, American Board of Otolaryngology
Fellowship
- Pediatric Otolaryngology, Rady Childrens Hospital of San Diego
Internship
- Otolaryngology, UCSF Medical Center House Staff
Degree
- MD, Northwestern University Feinberg School of Medicine
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
- Pediatric Otolaryngology
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
